Screener
Xeris Biopharma Holdings, Inc. XERS Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $121.75M+105% | $111.75M+91.2% | $111.04M+55.0% | $91.6M+54.6% | $59.29M+2.9% | ||
| $58.11M+9.5% | $56.3M+21.5% | $51.05M+26.3% | $53.75M+30.7% | $53.05M+25.0% | ||
| $80.93M+20.3% | $74.23M+40.9% | $68.67M+42.5% | $67.46M+49.5% | $67.28M+56.6% | ||
| $274.76M+48.1% | $251.68M+53.9% | $240.31M+43.3% | $224.02M+37.6% | $185.58M+8.9% | ||
| $4.83M-8.5% | $5.03M-4.3% | $4.95M-11.1% | $4.95M-11.9% | $5.28M-9.4% | ||
| $22.86M0.0% | $22.86M0.0% | $22.86M0.0% | $22.86M0.0% | $22.86M0.0% | ||
| $82.66M-11.6% | $85.37M-11.3% | $88.08M-11.0% | $90.79M-10.7% | $93.5M-10.4% | ||
| $411.91M+23.1% | $392.01M+24.3% | $383.53M+18.7% | $370.19M+15.3% | $334.69M+0.9% | ||
| $9.34M-1.3% | $11.47M+80.5% | $3.08M+34.3% | $6.53M-12.4% | $9.46M+63.2% | ||
| $63.78M— | —— | $0-100% | $0-100% | $0— | ||
| $189.57M+99.2% | $118.59M+24.7% | $109.57M+9.1% | $116.2M+27.7% | $95.17M+26.1% | ||
| $188.81M-13.6% | $221.22M+1.6% | $220.34M+1.5% | $219.47M+1.5% | $218.63M-5.1% | ||
| $421.64M+19.1% | $379M+8.1% | $369.84M+4.9% | $371.05M+6.2% | $353.99M+0.8% | ||
| $18K+12.5% | $18K+12.5% | $17K+13.3% | $17K+13.3% | $16K+6.7% | ||
| -$700.17M-2.5% | -$669.07M+1.8% | -$671.31M+0.1% | -$682.39M-2.3% | -$683.01M-4.9% | ||
| -$9.73M+49.6% | $13.01M+137% | $13.69M+146% | -$861K+97.0% | -$19.3M-0.1% | ||
| $411.91M+23.1% | $392.01M+24.3% | $383.53M+18.7% | $370.19M+15.3% | $334.69M+0.9% |
FAQ
- What are Xeris Biopharma Holdings, Inc.'s total assets?
- Xeris Biopharma Holdings, Inc. (XERS) holds $411.9M in total assets, up 23.1% year over year.
- How much debt does Xeris Biopharma Holdings, Inc. have?
- Xeris Biopharma Holdings, Inc. carries $289.4M in total debt against -$9.7M of shareholders' equity, a debt-to-equity ratio of 19.87.
- How much cash does Xeris Biopharma Holdings, Inc. have?
- Xeris Biopharma Holdings, Inc. holds $121.7M in cash and equivalents.
- Can Xeris Biopharma Holdings, Inc. cover its short-term obligations?
- Its current ratio is 1.45 — current assets exceed current liabilities.
- Where does Xeris Biopharma Holdings, Inc.'s balance sheet data come from?
- Every line is extracted from Xeris Biopharma Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
